Abnormal screening for gestational diabetes, maternal mood disorder, and preterm birth

Bipolar Disorders

Volumn 16, Issue 3, 2014, Pages 308-317

  Sit, Dorothy ^a   Luther, James ^b   Dills, John Louis Jesse ^b   Eng, Heather ^b   Wisniewski, Stephen ^b   Wisner, Katherine L ^c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Bipolar disorder; Gestational diabetes; Major depression; Preterm birth

Indexed keywords

ADULT; ADVERSE OUTCOME; ARTICLE; BIPOLAR DISORDER; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MATERNAL DISEASE; MATERNAL MOOD DISORDER; MATERNAL OBESITY; MATERNAL SMOKING; MOOD DISORDER; NEWBORN; OBSERVATIONAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SUBSTANCE USE; WEIGHT GAIN; BIRTH WEIGHT; DIABETES, GESTATIONAL; GESTATIONAL AGE; INFANT; MALE; MOOD DISORDERS; OUTCOME ASSESSMENT; PREGNANCY; PREMATURE BIRTH; YOUNG ADULT;

ADULT; BIRTH WEIGHT; DIABETES, GESTATIONAL; FEMALE; GESTATIONAL AGE; HUMANS; INFANT; MALE; MOOD DISORDERS; OUTCOME ASSESSMENT (HEALTH CARE); PREGNANCY; PREGNANCY OUTCOME; PREMATURE BIRTH; YOUNG ADULT;

EID: 84899964070     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/bdi.12129     Document Type: Article

References (42)

1. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 2004; 27 (Suppl. 1): S88-S90.
2. Kozhimannil KB, Pereira MA, Harlow BL. Association between diabetes and perinatal depression among low-income mothers. JAMA 2009; 301: 842-847.
3. Crowther CA, Hiller JE, Moss JR et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005; 352: 2477-2486.
4. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010; 303: 235-241.
5. Chu SY, Callaghan WM, Kim SY et al. Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care 2007; 30: 2070-2076.
6. Bodnar LM, Wisner KL, Moses-Kolko E, Sit DK, Hanusa BH. Prepregnancy body mass index, gestational weight gain, and the likelihood of major depressive disorder during pregnancy. J Clin Psychiatry 2009; 70: 1290-1296.
7. LaCoursiere DY, Barrett-Connor E, O'Hara MW, Hutton A, Varner MW. The association between prepregnancy obesity and screening positive for postpartum depression. BJOG 2010; 117: 1011-1018.
8. HAPO Study Cooperative Research Group, Metzger BE, Lowe LP et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991-2002.
9. Schmidt MI, Matos MC, Reichelt AJ et al. Prevalence of gestational diabetes mellitus - do the new WHO criteria make a difference? Brazilian Gestational Diabetes Study Group. Diabet Med 2000; 17: 376-380.
10. Buchanan TA, Xiang AH, Kjos SL et al. Antepartum predictors of the development of type 2 diabetes in Latino women 11-26 months after pregnancies complicated by gestational diabetes. Diabetes 1999; 48: 2430-2436.
11. Sheffield JS, Butler-Koster EL, Casey BM, McIntire DD, Leveno KJ. Maternal diabetes mellitus and infant malformations. Obstet Gynecol 2002; 100: 925-930.
12. Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 2008; 359: 61-73.
13. Wisner KL, Sit DK, Hanusa BH et al. Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes. Am J Psychiatry 2009; 166: 557-566.
14. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders - Patient Edition. Washington, DC: American Psychiatric Press, 1996.
15. Post RM, Roy-Byrne PP, Uhde TW. Graphic representation of the life course of illness in patients with affective disorder. Am J Psychiatry 1988; 145: 844-848.
16. Keller MB, Lavori PW, Friedman B et al. The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry 1987; 44: 540-548.
17. Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982; 144: 768-773.
18. O'Hara MW, Varner MW, Johnson SR. Assessing stressful life events associated with childbearing: the peripartum events scale. J Reprod Infant Psychol 1986; 4: 85-98.
19. Serretti A, Mandelli L. Antidepressants and body weight: a comprehensive review and meta-analysis. J Clin Psychiatry 2010; 71: 1259-1272.
20. Andersohn F, Schade R, Suissa S, Garbe E. Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus. Am J Psychiatry 2009; 166: 591-598.
21. Henderson DC, Cagliero E, Copeland PM et al. Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents. Arch Gen Psychiatry 2005; 62: 19-28.
22. Lepercq J, Coste J, Theau A, Dubois-Laforgue D, Timsit J. Factors associated with preterm delivery in women with type 1 diabetes: a cohort study. Diabetes Care 2004; 27: 2824-2828.
23. Ananth CV, Joseph KS, Oyelese Y, Demissie K, Vintzileos AM. Trends in preterm birth and perinatal mortality among singletons: United States, 1989 through 2000. Obstet Gynecol 2005; 105: 1084-1091.
24. Grote NK, Bridge JA, Gavin AR et al. A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry 2010; 67: 1012-1024.
25. Fried PA, Watkinson B, Dillon RF, Dulberg CS. Neonatal neurological status in a low-risk population after prenatal exposure to cigarettes, marijuana, and alcohol. J Dev Behav Pediatr 1987; 8: 318-326.
26. Goldschmidt L, Richardson GA, Willford J, Day NL. Prenatal marijuana exposure and intelligence test performance at age 6. J Am Acad Child Adolesc Psychiatry 2008; 47: 254-263.
27. Sapolsky RM, Romero LM, Lunch AU. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulator and preparative actions. Endocr Rev 2000; 21: 55-89.
28. Panagiotakos DB, Pitsavos C, Chrysohoou C et al. Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people; the ATTICA study. Eur Heart J 2004; 25: 492-499.
29. Monk C, Fitelson EM, Werner E. Mood disorders and their pharmacological treatment during pregnancy: is the future child affected? Pediatr Res 2011; 69: 3R-10R.
30. Kurki T, Hiilesmaa V, Raitasalo R, Mattila H, Tylikorkala O. Depression and anxiety in early pregnancy and risk for preeclampsia. Obstet Gynecol 2000; 95: 487-490.
31. Jutras-Aswad D, DiNieri JA, Harkany T, Hurd YL. Neurobiological consequences of maternal cannabis on human fetal development and its neuropsychiatric outcome. Eur Arch Psychiatry Clin Neurosci 2009; 259: 395-412.
32. Fride E. The endocannabinoid-CB receptor system: importance for development and in pediatric disease. Neuro Endocrinol Lett 2004; 25: 24-30.
33. Wang X, Dow-Edwards D, Anderson V, Minkoff H, Hurd YL. In utero marijuana exposure associated with abnormal amygdala dopamine D2 gene expression in the human fetus. Biol Psychiatry 2004; 56: 909-915.
34. Martin JA, Hamilton BE, Sutton PD et al. Births: Final Data for 2008. National Vital Statistics Reports; vol 59, no 1. Hyattsville, MD: National Center for Health Statistics, 2010.
35. Slattery MM, Morrison JJ. Preterm delivery. Lancet 2002; 360: 1489-1497.
36. Kirkegaard I, Obel C, Hedegaard M, Henriksen TB. Gestational age and birth weight in relation to school performance of 10-year-old children: a follow-up study of children born after 32 completed weeks. Pediatrics 2006; 118: 1600-1606.
37. Musselman DL, Betan E, Larsen H, Phillips LS. Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry 2003; 54: 317-329.
38. Landon MB, Spong CY, Thom E et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009; 361: 1339-1348.
39. Sit DK, Flint C, Svidergol D et al. Best practices: an emerging best practice model for perinatal depression care. Psychiatr Serv 2009; 60: 1429-1431.
40. Viguera AC, Nonacs R, Cohen LS et al. Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry 2000; 157: 179-184.
41. Cohen LS, Altshuler LL, Harlow BL et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA 2006; 295: 499-507.
42. Gjerdingen D, Katon W, Rich DE. Stepped care treatment of postpartum depression: a primary care-based management model. Women's Health Issues 2008; 18: 44-52.